法尼甾体X受体
肠道菌群
胆酸
CYP8B1
胆固醇7α羟化酶
鹅去氧胆酸
非酒精性脂肪肝
胆汁酸
G蛋白偶联胆汁酸受体
胆酸
化学
胆固醇
熊去氧胆酸
内科学
肝肠循环
生物化学
内分泌学
牛磺胆酸
肝X受体
脂肪肝
去唾液酸糖蛋白受体
水苏糖
葡萄糖稳态
脂质代谢
过氧化物酶体增殖物激活受体
脂肪酸
胆汁淤积
作者
Yanqi Li,Ying Fan,Yashi Zhang,Aizhen Zong,Fangling Du,Tongcheng Xu
标识
DOI:10.1021/acs.jafc.5c09242
摘要
Nonalcoholic fatty liver disease (NAFLD), driven by liver lipid accumulation, presents a global health challenge. Bile acid metabolism critically regulates cholesterol homeostasis, but whether prebiotic stachyose can modulate it for NAFLD intervention is unknown. In NAFLD mice induced by a high-fat-high-sucrose diet, stachyose (200 mg/kg bw, 20 weeks) expanded the bile acid pool, elevating the primary bile acids (such as cholic acid and chenodeoxycholic acids) in both serum and liver while reducing secondary bile acid levels. Mechanistically, stachyose upregulated the expression of bile acid synthesis enzymes CYP7A1 and CYP27A1 by inactivating the farnesoid X receptor (FXR)–small heterodimer partner (SHP) pathway, attributed to reducing the high-affinity ligand taurodeoxycholic acid level. Concurrently, it suppressed gut bile salt hydrolase (BSH) and 7α-dehydroxylase (7α-DH) activities, along with Bacteroides abundance, thereby suppressing secondary bile acid biotransformation. In conclusion, these findings highlight stachyose’s ability to restore bile acid homeostasis in NAFLD, providing a novel theoretical basis for preventive and therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI